ENGN Q4 2025 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$171,000

Operating Income

-$39M

Net Income

-$38M

EPS (Diluted)

$-0.74

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$221M

Total Liabilities

$54M

Stockholders' Equity

$168M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$480,000	-100.0%
Gross Profit	-$171,000	$240,000	-171.3%
Operating Income	-$39M	-$17M	-126.2%
Net Income	-$38M	-$15M	-147.6%